CannaPharmaRx Financials
| CPMD Stock | USD 0.01 0.0002 2.50% |
CannaPharmaRx |
Understanding current and past CannaPharmaRx Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CannaPharmaRx's financial statements are interrelated, with each one affecting the others. For example, an increase in CannaPharmaRx's assets may result in an increase in income on the income statement.
Please note, the presentation of CannaPharmaRx's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CannaPharmaRx's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CannaPharmaRx's management manipulating its earnings.
CannaPharmaRx Stock Summary
CannaPharmaRx competes with Phibro Animal, Curaleaf Holdings, China Pharma, Universe Pharmaceuticals, and Sonoma Pharmaceuticals. CannaPharmaRX, Inc. operates in the cannabis industry in Canada. The company was incorporated in 1998 and is based in Calgary, Canada. Cannapharmarx operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US13765D1090 |
| Business Address | 888 3rd Street |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cannapharmarx.com |
| Phone | 949 652 6838 |
| Currency | USD - US Dollar |
CannaPharmaRx Key Financial Ratios
There are many critical financial ratios that CannaPharmaRx's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CannaPharmaRx reports annually and quarterly.| Return On Equity | -2.51 | |||
| Return On Asset | -0.26 | |||
| Beta | 0.21 |
CannaPharmaRx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CannaPharmaRx's current stock value. Our valuation model uses many indicators to compare CannaPharmaRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CannaPharmaRx competition to find correlations between indicators driving CannaPharmaRx's intrinsic value. More Info.CannaPharmaRx is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CannaPharmaRx's earnings, one of the primary drivers of an investment's value.CannaPharmaRx Systematic Risk
CannaPharmaRx's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CannaPharmaRx volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on CannaPharmaRx correlated with the market. If Beta is less than 0 CannaPharmaRx generally moves in the opposite direction as compared to the market. If CannaPharmaRx Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CannaPharmaRx is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CannaPharmaRx is generally in the same direction as the market. If Beta > 1 CannaPharmaRx moves generally in the same direction as, but more than the movement of the benchmark.
CannaPharmaRx December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CannaPharmaRx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CannaPharmaRx. We use our internally-developed statistical techniques to arrive at the intrinsic value of CannaPharmaRx based on widely used predictive technical indicators. In general, we focus on analyzing CannaPharmaRx Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CannaPharmaRx's daily price indicators and compare them against related drivers.
| Downside Deviation | 18.78 | |||
| Information Ratio | 0.0756 | |||
| Maximum Drawdown | 202.42 | |||
| Value At Risk | (26.32) | |||
| Potential Upside | 22.22 |
Complementary Tools for CannaPharmaRx Pink Sheet analysis
When running CannaPharmaRx's price analysis, check to measure CannaPharmaRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannaPharmaRx is operating at the current time. Most of CannaPharmaRx's value examination focuses on studying past and present price action to predict the probability of CannaPharmaRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannaPharmaRx's price. Additionally, you may evaluate how the addition of CannaPharmaRx to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |